151 related articles for article (PubMed ID: 37002875)
21. Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
Macaluso FS; Maida M; Ventimiglia M; Renna S; Cottone M; Orlando A
Inflamm Bowel Dis; 2019 May; 25(6):987-997. PubMed ID: 30590590
[TBL] [Abstract][Full Text] [Related]
22. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
[TBL] [Abstract][Full Text] [Related]
23. Response to Placebo, Measured by Endoscopic Evaluation of Crohn's Disease Activity, in a Pooled Analysis of Data From 5 Randomized Controlled Induction Trials.
Duijvestein M; Jeyarajah J; Guizzetti L; Zou G; Parker CE; van Viegen T; VandeCasteele N; Khanna R; Van Der Aa A; Sandborn WJ; Feagan BG; D'Haens GR; Jairath V
Clin Gastroenterol Hepatol; 2020 May; 18(5):1121-1132.e2. PubMed ID: 31442599
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Singh S; Murad MH; Fumery M; Sedano R; Jairath V; Panaccione R; Sandborn WJ; Ma C
Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1002-1014. PubMed ID: 34688373
[TBL] [Abstract][Full Text] [Related]
25. Placebo Rates in Randomized Controlled Trials of Proctitis Therapy: A Systematic Review and Meta-Analysis Placebo Response in Proctitis.
De Silva TA; Alphonsus L; Ma C; Hogan M; Sedano R; Narula N; Danese S; Peyrin-Biroulet L; MacDonald JK; Singh S; Jairath V
J Crohns Colitis; 2023 Jan; 17(1):123-136. PubMed ID: 35930405
[TBL] [Abstract][Full Text] [Related]
26. Budesonide for maintenance of remission in Crohn's disease.
Benchimol EI; Seow CH; Otley AR; Steinhart AH
Cochrane Database Syst Rev; 2009 Jan; (1):CD002913. PubMed ID: 19160212
[TBL] [Abstract][Full Text] [Related]
27. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
MacDonald JK; Nguyen TM; Khanna R; Timmer A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007572. PubMed ID: 27885650
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
Behm BW; Bickston SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
[TBL] [Abstract][Full Text] [Related]
29. Sargramostim (GM-CSF) for induction of remission in Crohn's disease.
Roth L; Macdonald JK; McDonald JW; Chande N
Cochrane Database Syst Rev; 2011 Nov; (11):CD008538. PubMed ID: 22071853
[TBL] [Abstract][Full Text] [Related]
30. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Battat R; Duijvestein M; Guizzetti L; Choudhary D; Boland BS; Dulai PS; Parker CE; Nguyen TM; Singh S; Vande Casteele N; Pai RK; Feagan BG; Sandborn WJ; Jairath V
Am J Gastroenterol; 2019 May; 114(5):733-745. PubMed ID: 30694863
[TBL] [Abstract][Full Text] [Related]
31. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.
Iheozor-Ejiofor Z; Gordon M; Clegg A; Freeman SC; Gjuladin-Hellon T; MacDonald JK; Akobeng AK
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013210. PubMed ID: 31513295
[TBL] [Abstract][Full Text] [Related]
32. Budesonide for maintenance of remission in Crohn's disease.
Kuenzig ME; Rezaie A; Seow CH; Otley AR; Steinhart AH; Griffiths AM; Kaplan GG; Benchimol EI
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD002913. PubMed ID: 25141071
[TBL] [Abstract][Full Text] [Related]
33. Methotrexate for maintenance of remission in Crohn's disease.
Patel V; Wang Y; MacDonald JK; McDonald JW; Chande N
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD006884. PubMed ID: 25157445
[TBL] [Abstract][Full Text] [Related]
34. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
35. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Tsoulis DJ; MacDonald JK
Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
[TBL] [Abstract][Full Text] [Related]
36. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.
Gjuladin-Hellon T; Gordon M; Iheozor-Ejiofor Z; Akobeng AK
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD008414. PubMed ID: 31220875
[TBL] [Abstract][Full Text] [Related]
37. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
[TBL] [Abstract][Full Text] [Related]
38. Cyclosporine for induction of remission in Crohn's disease.
McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.
Rutgeerts P; Gasink C; Chan D; Lang Y; Pollack P; Colombel JF; Wolf DC; Jacobstein D; Johanns J; Szapary P; Adedokun OJ; Feagan BG; Sandborn WJ
Gastroenterology; 2018 Oct; 155(4):1045-1058. PubMed ID: 29909019
[TBL] [Abstract][Full Text] [Related]
40. Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.
Ford AC; Luthra P; Hanauer SB; Travis SP; Harris MS; Reinisch W
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):1981-90. PubMed ID: 25218669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]